Diep Van Nguyen | Disease | Best Researcher Award

Published on 11/07/202511/07/2025 by TOT Awards

Dr. Diep Van Nguyen | Disease | Best Researcher Award

Director at AVAC Vietnam Joint stock Company, Vietnam

Dr. Diep Van Nguyen is a visionary leader, scientist, and entrepreneur in veterinary vaccine development. He is currently the CEO and Director of the Center for Research and Development of Veterinary Vaccines at AVAC Viet Nam JSC, a leading company in animal health. With over 17 years of experience, Dr. Nguyen has spearheaded innovative vaccine projects, improved disease prevention strategies, and expanded global partnerships across Asia and Europe. He earned international recognition for his contributions to swine viral disease research and has published widely in high-impact journals. Dr. Nguyen holds a PhD from Miyazaki University (Japan) and has worked as a postdoctoral researcher at Kagoshima University. His leadership is grounded in science, innovation, and collaboration. Under his guidance, AVAC has become a cornerstone in Vietnam’s veterinary biotechnology sector. His contributions to ASF, PRRS, and PED vaccine research have positioned him as a global figure in veterinary immunology and biopharmaceutical innovation.

Professional Profile

ORCID

Education

Dr. Diep Van Nguyen began his academic journey at Vietnam National University of Agriculture, where he earned both his Doctor of Veterinary Medicine (2001–2006) and Master of Science in Veterinary Medicine (2007–2009). Pursuing advanced scientific training, he secured the prestigious Monbukagakusho Scholarship to complete his PhD in Veterinary Medicine at Miyazaki University, Japan (2013–2018). His doctoral studies focused on the molecular epidemiology of porcine epidemic diseases. Further honing his research expertise, Dr. Nguyen worked as a postdoctoral researcher at Kagoshima University (2018–2021), delving into gene-editing technologies and viral diagnostics. This internationally diverse education provided him with advanced insights into swine viral pathology and vaccine technology, laying the foundation for his impactful leadership in vaccine development. His academic background bridges Vietnamese clinical realities and Japanese research excellence, shaping his future innovations in veterinary medicine.

Work Experience

Dr. Diep Van Nguyen has cultivated a robust career that combines academia, research, and executive leadership. He began as a lecturer and researcher at the Vietnam National University of Agriculture, guiding students and participating in multiple international research collaborations. In 2021, he became the CEO of AVAC Viet Nam JSC, where he also leads the Center for Research and Development of Veterinary Vaccines. Under his leadership, AVAC launched pioneering products like AVAC ASF LIVE, PRRS LIVE, and LSD LIVE vaccines. He directed cross-border collaborations with international partners in the Philippines, India, Indonesia, and beyond. Dr. Nguyen’s work integrates regulatory compliance, scientific innovation, and commercial execution. He’s also contributed to internal process optimization and international patent submissions. His hands-on involvement in product development, strategic growth, and global networking has elevated Vietnam’s standing in veterinary pharmaceutical innovation.

🏆 Awards & Honors

Dr. Diep Van Nguyen has received notable national and international recognitions for his academic and scientific excellence. He was awarded the Best Student Award at the prestigious 7th International Symposium on Emerging and Re-emerging Pig Diseases (ISERPD 2015, Japan) for his contributions to swine viral epidemiology. From 2013 to 2018, he was a recipient of the Monbukagakusho Scholarship, Japan’s elite government-funded program for international scholars. In 2024, he received the distinguished Bao Son Prize, one of Vietnam’s top honors for scientific innovation and public service. These accolades reflect his deep commitment to combating viral diseases in livestock and his pioneering role in developing commercial vaccines. His recognition spans academic, industrial, and policy-making spheres, underscoring the impact of his research and leadership on both national food security and global animal health systems.

Research Focus

Dr. Nguyen’s research centers on swine viral diseases, particularly African Swine Fever (ASF), Porcine Reproductive and Respiratory Syndrome (PRRS), and Porcine Epidemic Diarrhea (PED). His core focus lies in the development of live-attenuated vaccines, viral genome sequencing, and molecular epidemiology. He is also actively advancing gene-editing techniques, specifically for creating robust viral vaccine platforms. His contributions include leading the creation of immortalized cell lines (e.g., DMAC) for effective virus propagation, submitting patents for novel vaccine strains, and evaluating cross-protection efficacy. His research integrates field-based outbreak data with laboratory innovations to develop scalable solutions for endemic and emerging diseases. Dr. Nguyen’s long-term vision is to provide affordable, effective, and globally deployable veterinary vaccines while maintaining strong regulatory standards and cross-national research collaborations.

Skills

Dr. Diep Van Nguyen possesses an exceptional mix of scientific, managerial, and entrepreneurial skills. His technical expertise includes gene-editing, molecular diagnostics, vaccine strain development, and cell line engineering. He is adept in strategic planning, product innovation, R&D leadership, and vaccine commercialization. As CEO, he oversees financial planning, regulatory compliance, market analysis, and strategic partnerships with global veterinary health companies. His communication fluency in English and intermediate proficiency in Japanese enable him to collaborate across borders effectively. He also leads cross-functional teams and drives innovation in disease prevention solutions. His contributions in regulatory navigation, grant acquisition, scientific publishing, and international presentations make him a sought-after expert in the veterinary vaccine industry. Additionally, Dr. Nguyen’s strength lies in uniting academic rigor with real-world applications, driving impactful outcomes in livestock health and food security.

Conclusion

Dr. Diep Van Nguyen is exceptionally suitable for the Research for Best Researcher Award. His visionary leadership, coupled with groundbreaking research and successful commercialization of vaccines, makes him a model scientist bridging academic excellence with real-world impact. His innovations in combating African Swine Fever and other major livestock diseases contribute to both regional food security and global animal health. A recognized scientific leader in Southeast Asia, Dr. Nguyen is not only advancing knowledge but also transforming veterinary public health systems.

Publications to Noted

Title: Establishment of an Immortalized Porcine Alveolar Macrophage Cell Line That Supports Efficient Replication of Porcine Reproductive and Respiratory Syndrome Viruses

🧑‍🤝‍🧑 Authors: Diep NV, Hayakawa-Sugaya Y, Ishikawa S, Kawaguchi H, Suda Y, Esaki M, Ozawa M

📅 Year: 2024

📊 Citations: 2

Title: Genotype II Live-Attenuated ASFV Vaccine Strains Unable to Completely Protect Pigs against the Emerging Recombinant ASFV Genotype I/II Strain in Vietnam

🧑‍🤝‍🧑 Authors: Diep NV, Duc NV, Ngoc NT, Dang VX, Tiep TN, Nguyen VD, Le VP

📅 Year: 2024

📊 Citations: 4

Title: Multiple variants of African swine fever virus circulating in Vietnam

🧑‍🤝‍🧑 Authors: Nguyen VT, Cho KH, Mai NTA, Park JY, Trinh TBN, Jang MK, Le VP

📅 Year: 2022

📊 Citations: 25

Title: Newly-designed primer pairs for the detection of type 2 porcine reproductive and respiratory syndrome virus genes

🧑‍🤝‍🧑 Authors: Fukunaga W, Hayakawa-Sugaya Y, Koike F, Van Diep N, Kojima I, Yoshida Y, Ozawa M

📅 Year: 2021

📊 Citations: 12

Title: Pathology of the outbreak of subgenotype 2.5 classical swine fever virus in northern Vietnam

🧑‍🤝‍🧑 Authors: Izzati UZ, Hoa NT, Lan NT, Diep NV, Fuke N, Hirai T, Yamaguchi R

📅 Year: 2021

📊 Citations: 17

Title: O/SEA/Mya-98 lineage foot-and-mouth disease virus was responsible for an extensive epidemic in Vietnam

🧑‍🤝‍🧑 Authors: Van Diep N, Ngoc TTB, Hoa LQ, Nga BTT, Kang B, Oh J, Le VP

📅 Year: 2020

📊 Citations: 9

Title: New tropisms of PEDV in pigs naturally coinfected with variants bearing deletions in the spike protein

🧑‍🤝‍🧑 Authors: Van Diep N, Choijookhuu N, Fuke N, Myint O, Izzati UZ, Suwanruengsri M, Yamaguchi R

📅 Year: 2020

📊 Citations: 32

Title: Severe degenerative changes in cryptorchid testes in Japanese black cattle

🧑‍🤝‍🧑 Authors: Fuke N, Kitahara G, Ito S, Van Diep N, Ping Teh AP, Izzati UZ, Yamaguchi R

📅 Year: 2020

📊 Citations: 14

Title: Development of indirect ELISA for detection of PEDV-specific antibodies (IgG) in naturally infected pigs

🧑‍🤝‍🧑 Authors: Myint O, Yoshida A, Sekiguchi S, Van Diep N, Fuke N, Izzati UZ, Yamaguchi R

📅 Year: 2019

📊 Citations: 28

Doutchi Mahamadou | Infectiology | Distinguished Scientist Award

Published on 03/07/202503/07/2025 by TOT Awards

Prof. Doutchi Mahamadou | Infectiologie | Distinguished Scientist Award

Head of Infectious and Tropical Diseases Department at André Salifou University, Niger

Dr. Mahamadou Elh Mahamane Doutchi is a seasoned infectious disease specialist and public health expert from Niger, serving as Associate Professor at the University of Zinder since 2022. He is the Deputy Head of the Department of Medicine and Medical Specialties and leads the Infectious Diseases Department at Zinder National Hospital. With over two decades of experience, he has made significant contributions in clinical care, medical education, and epidemic response. Dr. Doutchi has actively participated in managing outbreaks such as Rift Valley Fever and COVID-19 and contributed to malaria chemoprevention initiatives in Niger and Mali. As President of the Nigerian Society of Infectious Pathology (SONIPI), he plays a crucial role in shaping national infectious disease policy. His academic contributions include over 44 publications, three book chapters, and the supervision of numerous theses. Passionate about health system strengthening, he continues to influence both practice and policy through his research and teaching.

Professional Profile

ORCID

Education

Dr. Doutchi holds a Doctorate in General Medicine from the University Abdou Moumouni (2008), a Master’s in Public Health with a focus on Health Systems Engineering from the University of Marseille (2012), and multiple diplomas in infectious diseases. His specialized training includes a DFMS in Clinical and Biological Infectious Diseases from Marseille (2013), a DES in Infectious Diseases from Cheikh Anta Diop University (2014), and an inter-university diploma in Antibiology and Antibiotherapy from INSSA Burkina Faso. He also obtained his baccalaureate in Mathematics and Physical Sciences from Kouara High School in 1997. Between 2004 and 2024, he completed over 15 professional courses and internships to stay updated on emerging medical challenges. His multidisciplinary educational background, spanning medicine, public health, and microbiology, underpins his holistic approach to disease prevention, health promotion, and clinical management in both academic and field settings.

Work Experience

Dr. Doutchi’s extensive professional journey includes his ongoing role as a teaching-researcher at the University of Zinder since 2016, where he delivers over 170 hours of lectures and supervises 500 hours of clinical training yearly. His prior roles span multiple countries and organizations, including MSF and ALIMA, where he coordinated research and emergency responses in Niger, Mali, Nigeria, Chad, Senegal, and Côte d’Ivoire. He led projects on malaria chemoprevention, managed outbreaks (Rift Valley Fever, Lassa Fever), and supported malnutrition initiatives. He also interned at Hôpital La Conception in Marseille in 2013 and worked with MSF Switzerland (2008–2009). His work involves planning, implementation, training, supervision, and data analysis. He has demonstrated leadership in both crisis and stable environments, integrating research with real-time healthcare delivery. He remains a key figure in infectious disease management and public health intervention across Francophone Africa.

🏆 Awards & Honors

Dr. Doutchi has received wide recognition for his leadership in infectious disease management and health system strengthening. As President of the Nigerian Society of Infectious Pathology (SONIPI) since 2023, he has been instrumental in promoting research collaboration and policy formulation. He is also an active member of five prestigious medical societies, including the Société de Pathologie Infectieuse de Langue Française (SPILF) and the Société de Pathologie Exotique. His scientific presentations at key conferences such as the Journées Nationales d’Infectiologie (Saint-Malo) and CERMES (Niamey) have garnered attention for their relevance and rigor. Notably, his efforts in epidemic preparedness, malaria vaccine research, and community health programs have led to local and regional commendations, especially for his work during the COVID-19 pandemic and the Rift Valley Fever outbreak. His prolific academic output, mentorship, and cross-border collaboration reinforce his standing as a respected leader in global health.

Research Focus

Dr. Doutchi’s research spans malaria control, antimicrobial resistance, viral outbreaks, and public health preparedness. As co-investigator on multiple studies, he has addressed pressing health issues in West Africa, particularly the clinical and epidemiological characteristics of malaria, Rift Valley Fever, Lassa Fever, and HIV/AIDS. His interests lie in the operationalization of health interventions, such as seasonal malaria chemoprevention, vaccine campaigns, and outbreak response strategies. He also investigates antimicrobial usage patterns, aiming to curb resistance through education and policy reforms. His commitment to translational research ensures that findings are implemented in real-world settings. With over 44 peer-reviewed publications and 25 conference communications, Dr. Doutchi advocates for evidence-based practices tailored to low-resource environments. His work bridges academia and field operations, enhancing health system responsiveness through scientific innovation and cross-disciplinary collaboration.

Skills

Dr. Doutchi possesses a robust blend of clinical, academic, and public health skills. He excels in managing infectious disease cases, supervising clinical training, and designing university curricula. His capabilities include project planning and budget oversight, epidemiological and nutritional survey execution, and advanced data analysis using statistical software. A skilled communicator and educator, he has trained dozens of medical and paramedical staff and directed numerous health campaigns. His research expertise encompasses proposal writing, scientific publishing, and thesis supervision. His familiarity with international NGOs, such as ALIMA and MSF, has honed his ability to manage humanitarian crises and coordinate multidisciplinary teams. Notably, his ethical decision-making, cross-cultural sensitivity, and initiative-driven leadership have enabled him to navigate complex health emergencies effectively. He is also well-versed in inspection protocols, stakeholder engagement, and the development of innovative pedagogical tools for medical education.

Conclusion

Dr. Mahamadou Doutchi is highly suitable for the Research for Distinguished Scientist Award, particularly for his lifelong commitment to combating infectious diseases, developing public health infrastructure, and educating future medical professionals. His diverse experience across clinical, academic, and NGO sectors, combined with his leadership in handling health emergencies and mentoring junior researchers, exemplifies the criteria of a distinguished scientist with real-world impact.

Publications to Noted

First Cases of Dengue Fever Confirmed in the National Hospitals of Zinder and Niamey
Authors: Doutchi M., et al.
Journal: Case Reports in Infectious Diseases
Year: 2025 (Jan)

The resurgence of diphtheria in Zinder, Niger**
Authors: Doutchi M., Bara Abdoul‑Aziz A., Lamine M. M., Diongolé H., et al.
Journal: Infectious Diseases Now
Year: 2024 (Dec)

Circulation of Non‑falciparum Species in Niger: Implications for Malaria Diagnosis
Authors: Doutchi M., et al.
Journal: Open Forum Infectious Diseases
Year: 2024 (Aug 30)

Presentation and outcomes of Lassa fever in children in Nigeria: a prospective cohort study (LASCOPE)
Authors: Doutchi M., et al.
Journal: Journal of the Pediatric Infectious Diseases Society
Year: 2024 (Aug)

Inducible clindamycin resistance among clinical Gram‑positive cocci in a tertiary hospital in Niger Republic
Authors: Doutchi M.
Preprint: 2024 (Jun)

Health transformation toward universal healthcare coverage amidst conflict: examining the impact of international cooperation in Niger
Authors: Doutchi M.
Journal: Frontiers in Public Health
Year: 2024 (Mar)

Urinary Schistosomiasis in the Urban Community of Zinder (Niger): The Permanent Pond of In’birgui, an Epidemic Focus
Authors: Doutchi M.
Journal: Iranian Journal of Parasitology
Year: 2024 (Jan)

Fractional dosing to improve vaccination coverage, vaccine hesitancy, and cost‑effectiveness in Africa: a systematic review
Authors: Doutchi M.
Preprint: 2023 (Aug)

Metagenomic Direct Diagnosis of Polymicrobial Community‑Acquired Meningoencephalitis in Niger: A Case Report
Authors: Doutchi M.
Preprint: 2023 (Aug)

Missed opportunities to develop childhood cancer programmes in Africa
Authors: Doutchi M.
Journal: The Lancet Child & Adolescent Health
Year: 2023 (Jul)

Esmail M. El-Fakharany | Antiviral | Best Researcher Award

Published on 04/06/202504/06/2025 by TOT Awards

Prof. Dr. Esmail M. El-Fakharany | Antiviral | Best Researcher Award

Researcher at city of scientific research and technological applications, Egypt

Prof. Dr. Esmail Mohammed El-Fakharany is a distinguished Egyptian scientist in microbiology and biotechnology, currently serving as Professor in the Protein Research Department at the Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications. With a career dedicated to exploring the therapeutic applications of natural and recombinant proteins, he has made significant contributions in antiviral and anticancer research. Dr. El-Fakharany has published extensively in high-impact journals, including Scientific Reports – Nature, and has authored multiple book chapters. He is also an active mentor for MSc and Ph.D. students, a regular contributor to international conferences, and a patent innovator with numerous submissions to the Egyptian Patent Office. His research and mentorship have impacted various fields, including biotechnology, immunology, and molecular biology. Through teaching, research, and public engagement, he continues to foster innovation and scientific excellence both nationally and internationally. 🧬📚🦠

professional profile

Scopus Profile

ORCID

Education

Dr. El-Fakharany earned his Ph.D. in Microbiology with a minor in Biotechnology in 2012 from Al-Azhar University, Cairo. His doctoral thesis explored the antiviral activity of natural and recombinant lactoferrin, laying the foundation for his lifelong interest in therapeutic proteins. Prior to that, he completed an M.Sc. in Microbiology in 2009 at the same institution, with a focus on antiviral agents derived from microbial and natural sources. He also holds a Diploma in Public Health (Microbiology) from the High Institute of Public Health, Alexandria University (2006), and graduated with distinction in B.Sc. Microbiology from Al-Azhar University in 2003. His education reflects a strong interdisciplinary grounding in microbiology, biotechnology, and public health, preparing him to tackle challenges in drug development, protein engineering, and infection control. 📘🧫🎓

Work Experience

With over 20 years of research and teaching experience, Prof. El-Fakharany has held multiple academic and research roles culminating in his current position as Professor of Protein Research. His expertise includes therapeutic protein purification, immunoblotting, molecular biology, antiviral assays, and cell culture. He has played a pivotal role in training students across various disciplines including pharmacy, agriculture, and biotechnology, and has mentored numerous graduate theses. His experience also extends to managing scientific projects and participating in collaborative research initiatives. He regularly contributes to workshops, conferences, and summer schools, sharing his knowledge with local and international peers. He also actively contributes to training programs for visiting students and early-career researchers. As a result, Dr. El-Fakharany is recognized not only as a prolific scientist but also as a respected academic leader and mentor. 🧪👨‍🏫🔬

Research Focus

Dr. El-Fakharany’s research centers on the isolation, characterization, and therapeutic application of natural and recombinant proteins, particularly lactoferrin. His groundbreaking studies explore how these proteins can be harnessed as antiviral and anticancer agents, often using molecular biology and immunology tools to evaluate efficacy. He has specialized in using biotechnological methods to discover novel antiviral agents derived from microorganisms and other bioresources. His work also investigates cellular and molecular mechanisms underlying pathogen-host interactions, tumor progression, and immune responses. By integrating protein biochemistry with microbiology and tissue culture techniques, his research offers valuable insights for drug development, vaccine design, and therapeutic innovation. With a multidisciplinary approach that blends microbiology, molecular genetics, and bioengineering, Dr. El-Fakharany’s contributions aim to improve public health outcomes through novel biotherapeutics. 🧫💉🔍

Conclusion

Prof. Esmail Mohammed El-Fakharany is highly suitable for the Research for Best Researcher Award. His extensive experience, significant scientific contributions, dedication to innovation, and active mentorship align closely with the award’s objectives. With further emphasis on international collaboration and translational commercialization, he stands out as a strong and deserving candidate. 🏆🧪🌍

Publications to Noted

Title: Persulphate activation by ferrous sulphate for tertiary treatment of real domestic wastewater to meet the standards of irrigating food crops
Authors: Mohamed Fouad, Esmail M. El-Fakharany, Mohamed Mossad, Mahmoud Samy, Mohamed Gar Alalm
Journal: Journal of Water Process Engineering
Citations: 0
Year: 2025

Title: A novel nanocomposite fabrication of chitosan with tungstate oxide nanoplatform doped with bovine lactoperoxidase: characterizations and diverse biological assessments
Authors: Esmail M. El-Fakharany, Hamada El-Gendi, Mohamed H. El-Sayed, Mahmoud A. Abdelaziz, Ahmed I. Abd-Elhamid
Journal: Biomass Conversion and Biorefinery
Citations: 1
Year: 2025

Title: Metal-organic framework MIL-101(Fe) functionalized with folic acid as a multifunctional nanocarrier for targeted chemotherapy-photodynamic therapy
Authors: Eman Serag, Esmail M. El-Fakharany, Sherif F. Hammad, Mohamed E. El-Khouly
Journal: Biomaterials Science
Citations: 0
Year: 2025

Title: Chemopreventive effect of Pistacia vera leaf extract against mammary carcinoma induced by dimethyl-benz(a)anthracene in vivo and in vitro
Authors: Ali Gaithan Alkhathami, Esmail M. El-Fakharany, Mohamed H. El-Sayed, Hussam Askar, Mahmoud Ashry
Journal: Food and Chemical Toxicology
Citations: 4
Year: 2025

Title: Statistical optimization of hyaluronidase production by Ochrobactrum intermedium MEFS strain along with in vivo application in the treatment of aesthetic filler complications
Authors: Fafy A. Mohammed, Mai A. Ebraheem, Esmail M. El-Fakharany, Sherif Moussa Husseiny
Journal: International Journal of Biological Macromolecules
Citations: 0
Year: 2025

Title: Fabrication and characterization of lactoperoxidase coated the modified graphene oxide-based nanocomposite for medical applications
Authors: Abdelaziz A. Nayl, Esmail M. El-Fakharany, Ahmed I. Abd-Elhamid, Ashraf A. Aly, Stefan J. Bräse
Journal: International Journal of Biological Macromolecules
Citations: 0
Year: 2025

Title: Corrigendum to “Comprehensive insight into recent algal enzymes production and purification advances: Toward effective commercial applications: A review”
Authors: Esmail M. El-Fakharany, Ahmed K. Saleh, Yousra A. El-Maradny, Wafa Mazi, Hamada El-Gendi
Journal: International Journal of Biological Macromolecules
Citations: 0
Year: 2024

Diep Van Nguyen | Disease | Best Researcher Award

Dr. Diep Van Nguyen | Disease | Best Researcher Award

Professional Profile

Education

Work Experience

🏆 Awards & Honors

Research Focus

Skills

Conclusion

Publications to Noted

Doutchi Mahamadou | Infectiology | Distinguished Scientist Award

Prof. Doutchi Mahamadou | Infectiologie | Distinguished Scientist Award

Professional Profile

Education

Work Experience

🏆 Awards & Honors

Research Focus

Skills

Conclusion

Publications to Noted

Esmail M. El-Fakharany | Antiviral | Best Researcher Award

Prof. Dr. Esmail M. El-Fakharany | Antiviral | Best Researcher Award

professional profile

Education

Work Experience

Research Focus

Conclusion

Publications to Noted

RECOMMENDED

Mail us